The underlying mechanism of SSRI-induced DO is that serotoninergic inputs from the dorsal raphe nucleus stimulate PRL-releasing factors in the paraventricular nucleus [39], resulting in hyperprolactinemia and subsequent suppression of T production as described above [14]. Here, PRL is linked to hyperprolactinemia.